Tag: Biosensors
EuroPCR 2023: Biolimus-coated balloon fails to match paclitaxel for in-stent restenosis
Results of the first study of a first-generation drug-coated balloon (DCB) with a biolimus coati...
Blue Sail Medical and Biosensors International acquire TAVI company NVT
Blue Sail Medical has completed the acquisition of Swiss based company NVT AG. The closure of th...
Keith Oldroyd to become CMO at Biosensors
Biosensors International Group has announced the appointment of Keith G Oldroyd to the post of c...
Polymer-free stents have similar performance profiles, except in diabetes
A pooled data analysis comparing the Cre8 amphilimus-eluting stent (Alvimedica) and the BioFreed...
TCT 2018: LEADERS FREE II confirm favourable results for BioFreedom
The primary endpoint results of the LEADERS FREE II trial were presented at the 2018 Transcathet...
First patient enrolled in the US LEADERS FREE II trial of BioFreedom
Biosensors has announced that the first patient has been enrolled in LEADERS FREE II—the BioFree...
